Cullinan Therapeutics Cash Flow Statement (2020-2023) | CGEM

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Operating Activities
Net Income 1.42M-16.44M-18.26M-34.21M-12.86M174.06M-24.89M-27.07M-58.14M-32.21M-39.18M-25.56M
Share-based Compensation 3.51M4.17M4.56M12.14M6.57M8.61M5.27M7.51M7.26M7.92M7.74M7.52M
Deferred Taxes -19.57M
Gains from Sales and Divestitures 0.13M0.28M0.05M
Gains from Investment Securities 4.62M4.62M4.62M10.70M0.02M-0.13M32.69M5.22M0.07M4.63M-9.14M
Non-cash Items 75.80M66.00M
Cash from Operations -5.01M-6.25M-9.07M-9.44M-1.51M-16.20M-10.55M-15.17M-21.91M-25.42M-54.35M-24.98M-51.00M-31.01M-34.14M-18.13M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.06M0.07M0.08M0.08M0.08M
Change in Working Capital
Change in Account Payables 0.17M1.87M-0.98M4.52M-4.12M-2.37M0.52M1.15M3.14M-3.21M-1.58M1.15M-0.63M0.46M-1.54M1.54M
Change in Accured Expenses -0.76M-0.21M2.74M-0.02M1.79M-1.60M1.60M2.77M1.03M4.69M1.23M1.58M2.64M-2.82M5.17M5.06M
Change in Taxes 46.50M-35.10M-7.12M-0.07M-4.21M
Investing Activities
Capital Expenditures 0.00M0.00M0.00M-0.00M0.25M0.88M0.16M0.05M
Change in Acquisitions & Divestments 4.20M11.53M14.24M32.94M12.04M58.90M59.71M61.40M91.73M67.20M61.40M132.60M104.48M93.61M93.82M117.48M
Cash from Investing Activities -26.89M11.97M-1.94M11.44M-137.73M-154.59M-25.59M-15.86M34.71M300.85M-57.98M-28.61M15.18M12.11M-42.96M51.47M
Financing Activities
Other financing activities 13.70M3.51M4.17M4.56M21.69M6.57M8.61M5.27M26.80M7.26M7.92M7.74M7.52M
Debt Issuance and Repayment
Long-Term Debt Issuances 0.80M1.40M
Change in Capital Stock
Shares Issued 14.25M0.80M267.27M1.59M-0.43M-0.04M38.42M
Shares Repurchased 0.21M6.36M
Preferred Shares Issued 0.80M1.40M0.17M1.82M
Misc.
Cash from Financing Activities 14.04M1.21M124.90M264.58M0.92M0.58M2.70M3.54M2.01M1.43M-32.91M1.79M38.60M0.11M0.25M
Change in Cash -17.87M5.72M-9.81M126.90M125.34M-169.87M-35.56M-28.33M16.34M277.44M-110.91M-86.50M-34.02M19.71M-76.99M33.59M
Beginning Cash Balance 17.87M-5.72M9.81M41.30M168.20M293.54M480.96M88.11M298.56M333.56M686.91M242.66M424.72M472.09M543.39M-33.59M
Free Cash Flow -5.02M-6.25M-9.07M-9.44M-1.51M-16.20M-10.55M-15.17M-21.91M-25.42M-54.60M-25.86M-51.16M-31.05M-34.14M-18.13M
Net Cash Flow -17.87M5.72M-9.81M126.90M125.34M-169.87M-35.56M-28.33M16.34M277.44M-110.91M-86.50M-34.02M19.71M-76.99M33.59M